Chinook Therapeutics brings in $106M ahead of reverse merger

Chinook Therapeutics, a Vancouver, B.C. based company with offices in Seattle, raised $106 million in advance of an upcoming reverse merger with Berkeley, California-based Aduro Biotech, Inc. The combined company will focus on Chinook’s pipeline of drugs combating kidney disease, with financing going towards several drugs in development and clinical trials at the company.

READ THE STORY at Puget Sound Business Journal »